Can Africa achieve herd immunity?
- PMID: 34852844
- PMCID: PMC8636285
- DOI: 10.1186/s41256-021-00231-1
Can Africa achieve herd immunity?
Abstract
The World Health Organization described herd immunity, also known as population immunity, as the indirect fortification from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous exposure to infection. The emergence of COVID-19 vaccine is a step towards the achievement of herd immunity. Over one billion people across the globe have been vaccinated and Africa recorded only 2%. The objective of this article was to develop a forecast of the number of people to be vaccinated to achieve herd immunity in the 13 WHO-identified priority African countries for COVID-19. Herd immunity is achieved when one infected person in a population causes less than one secondary case on average, corresponding to the effective basic reproduction number (R0). Vaccine delivery and distribution infrastructure including the cold chain remains weak. Vaccine hesitancy is also one of the limiting factors that may hinder herd immunity in Africa. In order to achieve herd immunity globally, African countries should not be excluded in fair and equal distribution of vaccines. Relevant stakeholders should foster commitment as well as community sensitization on COVID-19 vaccines and integration of COVID-19 vaccines in existing healthcare services.
Keywords: Africa; COVID-19; Herd immunity; Vaccine.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests. Don Eliseo Lucero-Prisno is the Deputy Editor in Chief of Global Health Research and Policy. Hao Li is the Editor in Chief of Global Health Research and Policy. Both of them were not involved in the review of decision related to the manuscript.
Similar articles
-
Overcoming COVID-19 in West African countries: is herd immunity an option?Pan Afr Med J. 2020 Jul 6;35(Suppl 2):103. doi: 10.11604/pamj.supp.2020.35.2.24217. eCollection 2020. Pan Afr Med J. 2020. PMID: 33282058 Free PMC article.
-
R0 of COVID-19 and its impact on vaccination coverage: compared with previous outbreaks.Hum Vaccin Immunother. 2021 Nov 2;17(11):3850-3854. doi: 10.1080/21645515.2020.1865046. Epub 2021 Oct 6. Hum Vaccin Immunother. 2021. PMID: 34612165 Free PMC article. Review.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.Pan Afr Med J. 2021 Aug 20;39:255. doi: 10.11604/pamj.2021.39.255.30331. eCollection 2021. Pan Afr Med J. 2021. PMID: 34707756 Free PMC article.
-
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.Hum Vaccin Immunother. 2022 Dec 31;18(1):2031455. doi: 10.1080/21645515.2022.2031455. Epub 2022 Feb 22. Hum Vaccin Immunother. 2022. PMID: 35192781 Free PMC article.
Cited by
-
Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target.Trop Med Health. 2022 Feb 15;50(1):15. doi: 10.1186/s41182-022-00407-6. Trop Med Health. 2022. PMID: 35168667 Free PMC article.
-
COVID-19 vaccination intention among internally displaced persons in complex humanitarian emergency context, Northeast Nigeria.PLoS One. 2024 Aug 30;19(8):e0308139. doi: 10.1371/journal.pone.0308139. eCollection 2024. PLoS One. 2024. PMID: 39213303 Free PMC article.
-
Achieving COVID-19 herd immunity in Ethiopia.Public Health Chall. 2023 Jun 19;2(2):e99. doi: 10.1002/puh2.99. eCollection 2023 Jun. Public Health Chall. 2023. PMID: 40495867 Free PMC article.
-
Road to achieving COVID-19 herd immunity in Niger Republic: Challenges and recommendations.Public Health Chall. 2022 Dec;1(4):e38. doi: 10.1002/puh2.38. Epub 2022 Dec 7. Public Health Chall. 2022. PMID: 37519310 Free PMC article.
-
Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries.Clin Pathol. 2024 May 14;17:2632010X241254961. doi: 10.1177/2632010X241254961. eCollection 2024 Jan-Dec. Clin Pathol. 2024. PMID: 38746645 Free PMC article. No abstract available.
References
-
- Population Reference Bureau. International Data. Accessed 03 May 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical